Similar articles

• Jaydess® levonorgestrel intrauterine system.

  Melvin L, Scott J, Craik J. Melvin L, et al. J Fam Plann Reprod Health Care. 2014 Jul;40(3):165-9. doi: 10.1136/jfprhc-2014-100980. J Fam Plann Reprod Health Care. 2014. PMID: 24939481 Review. No abstract available.
• [Reasons for removal of intrauterine devices among women in general practice].

  Kolding L, Majeed HG. Kolding L, et al. Ugeskr Laeger. 2013 Mar 25;175(13):884-6. Ugeskr Laeger. 2013. PMID: 23582897 Danish.
• von Willebrand's disease diagnosed after menorrhagia worsened from levonorgestrel intrauterine system.

  Lukes AS, Perry S, Ortel TL. Lukes AS, et al. Obstet Gynecol. 2005 May;105(5 Pt 2):1223-6. doi: 10.1097/01.AOG.0000157758.94890.59. Obstet Gynecol. 2005. PMID: 15863590
• Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.

  Wildemeersch D, Schacht E. Wildemeersch D, et al. Eur J Contracept Reprod Health Care. 2001 Jun;6(2):93-101. Eur J Contracept Reprod Health Care. 2001. PMID: 11518454
• [Mirena--the first intrauterine contraceptive therapeutic system].

  Rachev E. Rachev E. Akush Ginekol (Sofiia). 2001;40 Suppl 6:3-6. Akush Ginekol (Sofiia). 2001. PMID: 11803883 Review. Bulgarian. No abstract available.